Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01454830 · ClinicalTrials.gov registry record · Phase 1

Tailored Intervention to Promote Positive Airway Pressure Adherence

A Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 1
Development phase
118
Enrollment target
1
Study location

NCT01454830: Completed Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance, sponsored by Milton S. Hershey Medical Center.

NCT01454830 is a Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 118 participants, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01454830, a Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility of a tailored (i.e., individualized) intervention to promote adherence to continuous positive airway pressure therapy (CPAP) in adults with newly-diagnosed, CPAP treated, obstructive sleep apnea.

Primary Outcome

Mean CPAP use, hrs/night

Interventions

  • OTHER Usual care
  • BEHAVIORAL Tailored

Study Locations (1)

Pennsylvania

  • Penn State Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2011-11
Est. Completion 2014-03
Phase Phase 1
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01454830 record still lists

NCT01454830 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (55% lower).

The record links to 2 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT01454830 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01454830 about?

NCT01454830 is a clinical study titled "Tailored Intervention to Promote Positive Airway Pressure Adherence". The purpose of this study is to examine the feasibility of a tailored (i.e., individualized) intervention to promote adherence to continuous positive airway pressure therapy (CPAP) in adults with newly-diagnosed, CPAP treated, obstructive sleep apnea.

What is the current status of trial NCT01454830?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2011-11. Estimated completion is 2014-03.

What conditions does trial NCT01454830 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Patient Compliance.

What interventions are being tested in trial NCT01454830?

The interventions under investigation include: Usual care (OTHER), Tailored (BEHAVIORAL).

Who is sponsoring clinical trial NCT01454830?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01454830 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01454830's enrollment target sits among peer trials

118 17th of 45 higher than 29 of 45 other Sleep Apnea, Obstructive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01454830, the US trial registry maintained by the National Library of Medicine. NCT01454830 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.